NCT00647894View on ClinicalTrials.gov

Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
Healthy
Interventions
DRUG

Alprazolam Extended-Release Tablets 1 mg

DRUG

Xanax XR Tablets 1 mg

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00647894 - Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg | Biotech Hunter | Biotech Hunter